Greenland Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Greenland Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.71M	Sell	80,000 -27,500	-26%	-$916K	0.33%	60
2026 Q1	$3.24M	Sell	107,500 -6,000	-5%	-$193K	0.41%	53
2025 Q4	$3.54M	Sell	113,500 -12,547	-10%	-$309K	0.38%	74
2025 Q3	$2.55M	Buy	+126,047	New	+$2.21M	0.25%	111
2025 Q1	–	Sell	-20,000	Closed	-$441K	–	430
2024 Q4	$441K	Buy	+20,000	New	+$364K	0.07%	212

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Greenland Capital Management's TEVA Position: Q2 2026 in Review

Greenland Capital Management reduced its Teva Pharmaceuticals (TEVA) stake by 26% in Q2 2026, selling an estimated $916K and leaving 80,000 shares worth $2.71M. The position accounts for 0.33% of the portfolio, ranked #60.

Greenland Capital Management first reported a position in TEVA in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.54M in Q4 2025. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Greenland Capital Management held 80,000 shares of Teva Pharmaceuticals worth $2.71M as of Q2 2026.
Greenland Capital Management sold 27,500 Teva Pharmaceuticals shares in Q2 2026, an estimated $916K.
Teva Pharmaceuticals made up 0.33% of Greenland Capital Management's portfolio in Q2 2026, its #60 holding.
Greenland Capital Management first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
Greenland Capital Management's Teva Pharmaceuticals position peaked at $3.54M in Q4 2025.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Greenland Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.